Oculis Holding AG (OCS) Common Equity (2020 - 2026)
Oculis Holding AG (OCS) reported Common Equity of $277.51 million for Q2 2026, up 60.6% from $172.84 million a year earlier and up 10.5% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Oculis Holding AG posted Common Equity of $245.32 million, up 194.1% from FY2024.
- By year, Common Equity came in at $83.41 million in FY2024 (-21.1%), $105.66 million in FY2023, -$102.72 million in FY2022 and -$66.71 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q4 2020.
- Year over year, Common Equity has now increased in each of the last six quarters, with growth averaging 56.3% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q4 2025 (growth of 192.9%); the low point was Q4 2024 (a decline of 20.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $251.12 million (Q1 2026), $245.32 million (Q4 2025) and $163.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Oculis Holding AG | 473.32 Mn | 473.32 Mn | - | 277.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 277.51 Mn |
| Mar 31, 2026 | 251.12 Mn |
| Dec 31, 2025 | 245.32 Mn |
| Sep 30, 2025 | 163.26 Mn |
| Jun 30, 2025 | 172.84 Mn |
| Mar 31, 2025 | 180.88 Mn |
| Dec 31, 2024 | 83.77 Mn |
| Sep 30, 2024 | 109.91 Mn |
| Jun 30, 2024 | 124.76 Mn |
| Mar 31, 2024 | 90.55 Mn |
| Dec 31, 2023 | 105.66 Mn |
| Sep 30, 2023 | 119.56 Mn |
| Jun 30, 2023 | 130.34 Mn |
| Dec 31, 2022 | -101.72 Mn |
| Dec 31, 2021 | -66.11 Mn |
| Dec 31, 2020 | -48.29 Mn |
API Access
Oculis Holding AG Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();